Markets.com Logo

GLAXO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2782.2338$
  • Previous Close
    2797.8359$
  • 52 Week Change
    1619.42$
  • Day Range
    -15.60$
  • 52 Week High/Low
    1896.2767$ - 3515.7$
  • Dividend Per Share
    0
  • Market cap
    471 712 M$
  • EPS
    9.89
  • Beta
    0.064
  • Volume
    --

About

GLAXO.NSE refers to the stock of GlaxoSmithKline Pharmaceuticals Limited listed on the National Stock Exchange of India (NSE). It represents a share in the ownership of this pharmaceutical company, allowing investors to participate in its financial performance. The company is a subsidiary of GlaxoSmithKline plc, a global research-based pharmaceutical and healthcare company.
AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

Frances Wang|--
RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

Frances Wang|--
Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Frances Wang|--
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--

Factors

Government Regulations: Changes in drug pricing policies and regulatory approvals can significantly impact GlaxoSmithKline's (GSK) revenue and profitability.

Clinical Trial Outcomes: Positive results from clinical trials for new drugs typically boost investor confidence, while negative results can lead to stock declines.

Economic Conditions: Overall economic growth or recession in key markets can influence healthcare spending and demand for GSK's products.

Competition: The emergence of new competitors or generic versions of existing drugs can erode GSK's market share and profitability.

Patent Expiry: When patents expire on key drugs, generic versions become available, leading to lower sales and reduced revenue for GSK.

Mergers and Acquisitions: M&A activity in the pharmaceutical sector can affect investor sentiment and the perceived value of GSK's stock.

Global Health Events: Pandemics or outbreaks of infectious diseases can impact demand for vaccines and antiviral medications.

Company-Specific News: Announcements about new product launches, earnings reports, or strategic initiatives can influence investor behavior.

Investor Sentiment: General market optimism or pessimism can affect trading volumes and stock valuations across the board.

Currency Fluctuations: Changes in exchange rates can impact GSK's international earnings and overall financial performance.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

What does CFD mean in trading: How to start CFD Trading in 2026?

What does CFD mean in trading: How to start CFD Trading in 2026?

Ghko B|--
A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--